Pages that link to "Q36493180"
Jump to navigation
Jump to search
The following pages link to Management of osteoporosis in postmenopausal women: 2006 position statement of The North American Menopause Society (Q36493180):
Displaying 50 items.
- Calcium Supplementation in Clinical Practice: A Review of Forms, Doses, and Indications (Q22306250) (← links)
- Estrogen and progestogen use in postmenopausal women: July 2008 position statement of The North American Menopause Society (Q24658109) (← links)
- Nuclear receptors in bone physiology and diseases (Q26853017) (← links)
- An overview on the treatment of postmenopausal osteoporosis (Q27013070) (← links)
- Plasma organochlorine concentrations and bone ultrasound measurements: a cross-sectional study in peri-and postmenopausal Inuit women from Greenland (Q30542621) (← links)
- Bone mass, bone strength, and their relationship in developing CD-1 mice (Q33283991) (← links)
- Bisphosphonate-induced osteonecrosis of the jaws: review, clinical implications and case report (Q33594764) (← links)
- Safety of bazedoxifene in a randomized, double-blind, placebo- and active-controlled Phase 3 study of postmenopausal women with osteoporosis (Q33613016) (← links)
- Effects of resistance training and soy isoflavone on body composition in postmenopausal women (Q33861136) (← links)
- Osteoporosis therapies: evidence from health-care databases and observational population studies (Q34242906) (← links)
- Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 (Q34496410) (← links)
- Experimental osteoporosis induced by ovariectomy and vitamin D deficiency does not markedly affect fracture healing in rats (Q34646272) (← links)
- Depression and osteoporosis: a research synthesis with meta-analysis (Q35059720) (← links)
- The effect of breast-feeding duration on bone mineral density in postmenopausal Turkish women: a population-based study (Q35674199) (← links)
- Cost-effectiveness of different screening strategies for osteoporosis in postmenopausal women (Q35868662) (← links)
- Approach to the prostate cancer patient with bone disease (Q36360754) (← links)
- An aerobic weight-loaded pilot exercise intervention for breast cancer survivors: bone remodeling and body composition outcomes (Q36520117) (← links)
- Intravenous ibandronate: in the treatment of osteoporosis (Q36586906) (← links)
- Association of the MTHFR C677T polymorphism and bone mineral density in postmenopausal women: a meta-analysis (Q36681939) (← links)
- Regulators of G protein signaling 12 promotes osteoclastogenesis in bone remodeling and pathological bone loss. (Q36751534) (← links)
- Is treatment of early postmenopausal women with bisphosphonates justified? (Q36823017) (← links)
- Patient assessment in the diagnosis, prevention, and treatment of osteoporosis (Q36824450) (← links)
- Pharmacologic and nonpharmacologic management of osteoporosis (Q36859988) (← links)
- Risedronate once monthly: a potential new regimen for the treatment of postmenopausal osteoporosis (Q36897425) (← links)
- Clinical challenges in the management of osteoporosis (Q36897449) (← links)
- Osteoporosis guidelines (Q36946813) (← links)
- Fracture prevention strategies in patients presenting to Australian hospitals with minimal-trauma fractures: a major treatment gap. (Q36951275) (← links)
- Hormone therapy for the prevention of bone loss in menopausal women with osteopenia: is it a viable option? (Q36993374) (← links)
- Factors associated with a second hip fracture: a systematic review. (Q37023421) (← links)
- The use of calcium and vitamin D in the management of osteoporosis (Q37052780) (← links)
- Differences in site-specific fracture risk among older women with discordant results for osteoporosis at hip and spine: study of osteoporotic fractures (Q37297932) (← links)
- Zoledronic acid: a review of its use in the treatment of osteoporosis (Q37306784) (← links)
- Bazedoxifene: a selective estrogen-receptor modulator (Q37346144) (← links)
- Ibandronate: a review of its use in the management of postmenopausal osteoporosis (Q37354137) (← links)
- Teriparatide: a review of its use in osteoporosis. (Q37354140) (← links)
- Depression as a risk factor for osteoporosis (Q37393313) (← links)
- Prevention, screening, and management of osteoporosis: an overview of the current strategies (Q37566044) (← links)
- Evaluation of compliance with osteoporosis treatment guidelines after initiation of a pharmacist-run osteoporosis service at a family medicine clinic (Q37614089) (← links)
- Bazedoxifene: a novel selective estrogen receptor modulator for postmenopausal osteoporosis (Q37698607) (← links)
- What is the best balance of benefits and risks among anti-resorptive therapies for postmenopausal osteoporosis? (Q37716669) (← links)
- Osteoporosis update: effective prevention and treatment (Q37763162) (← links)
- Primary antiphospholipid syndrome in premenopausal women: low vitamin D, high fat mass and maintained bone mineral mass (Q37763796) (← links)
- Tissue-selective estrogen complexes: a promising option for the comprehensive management of menopausal symptoms (Q37768158) (← links)
- Evidence-based risk assessment and recommendations for physical activity: arthritis, osteoporosis, and low back pain (Q37908104) (← links)
- Consensus statements on osteoporosis diagnosis, prevention, and management in the Philippines (Q37911560) (← links)
- Healthy diet to prevent cardiovascular diseases and osteoporosis: the experience of the 'ProSa' project. (Q38032324) (← links)
- Association of homocysteine, vitamin B12, and folate with bone mineral density in postmenopausal women: a meta-analysis (Q38160172) (← links)
- [Menopausal hormone therapy]. (Q39329106) (← links)
- Inhibitory effects of iron on bone morphogenetic protein 2-induced osteoblastogenesis. (Q39594889) (← links)
- Effects of plyometric exercise session on markers of bone turnover in boys and young men. (Q40897537) (← links)